Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & EMBASE  
     Home | Subscribe | Feedback  

PAPERS
[View FULLTEXT] [Download PDF
 
Year : 1995  |  Volume : 41  |  Issue : 4  |  Page : 95-8  

The impact of cisplat based chemotherapy on advanced ovarian cancer.

GR Prasad, AV Dalal, HB Tongaonkar, S Chatterjee, MR Kamat 
 Gynecologic Oncology Service, Tata Memorial Hospital, Parel, Bombay.

Correspondence Address:
G R Prasad
Gynecologic Oncology Service, Tata Memorial Hospital, Parel, Bombay.

Cisplatinum based chemotherapy has become the standard treatment for ovarian cancers due to its proved superiority over non-cisplat based regimes. However, the therapeutic impact of cisplat based regimes compared to cheaper non-cisplatinum based regimes is questionable when multiple variables such as residual disease, histologic type, grade are introduced. This report is a study of 110 Stage III ovarian cancer patients from 1985-89, with cisplat (n = 69) and non cisplat (n = 41) based chemotherapy. The results of both regimes with reference to the multiple variable factors are presented. We conclude that cisplat based regimes appear to be superior to non-cisplat based regimes except probably in poorly differentiated ovarian tumors where the results were similar with either regimen.


How to cite this article:
Prasad G R, Dalal A V, Tongaonkar H B, Chatterjee S, Kamat M R. The impact of cisplat based chemotherapy on advanced ovarian cancer. J Postgrad Med 1995;41:95-8


How to cite this URL:
Prasad G R, Dalal A V, Tongaonkar H B, Chatterjee S, Kamat M R. The impact of cisplat based chemotherapy on advanced ovarian cancer. J Postgrad Med [serial online] 1995 [cited 2019 Oct 19 ];41:95-8
Available from: http://www.jpgmonline.com/article.asp?issn=0022-3859;year=1995;volume=41;issue=4;spage=95;epage=8;aulast=Prasad;type=0


 
Saturday, October 19, 2019
 Site Map | Home | Contact Us | Feedback | Copyright  and disclaimer